Skip to content
Head to head

TransMedics vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: TMDX · ABT

Updated 3 minutes ago

1-year performance, rebased to 100

TMDX -24.8%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories has the highest Quant Rating (22); Abbott Laboratories has done best over the past year (-15%); Abbott Laboratories pays the highest dividend yield.
TMDXABT
Snapshot
SectorMedical DevicesMedical Devices
Last price85.25103.00
Change today-9.33%-0.84%
1-year return-31.2%-15.4%
Market cap$2.96B$178.39B
52-week range60.11 – 156.0080.89 – 126.70
Valuation
P/E (TTM)23.2338.29
P/E percentile, own 5-yr range67th99th
P/B5.383.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)4.873.72
Net profit (TTM)$169.15M$6.44B
Revenue (TTM)$727.65M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+41.1%+14.5%
Gross margin58.6%56.9%
Operating margin11.9%13.8%
Net margin19.9%9.7%
Free cash flow (TTM)$44.70M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership103.7%81.2%
Insider activity (12mo)30 buy / 19 sell36 buy / 12 sell
Short interest (% of float)25.6%1.1%
Analyst consensus78% buy / 22% hold (9)93% buy / 7% hold (15)
Analyst price target$105 (+23%)$122 (+18%)
StockVane view
StockVane Quant RatingE (11)D (22)
Company
Employees898115,000
Founded19981900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.